Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.815
-0.050 (-1.75%)
Oct 2, 2026, 4:08 PM HKT

HKG:0241 Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, HKG:0241 stock has a consensus rating of "Buy" and an average price target of $4.59. The average 1-year stock price forecast is 63.06% higher than the current stock price, while the lowest is $2.80 (-0.53%) and the highest is $8.01 (+184.55%).

Price Target: $4.59 (+63.06%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.80$4.59$4.24$8.01
Change-0.53%+63.06%+50.62%+184.55%

Analyst Ratings

The average analyst rating for HKG:0241 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy101010888
Buy111112
Hold555443
Sell000000
Strong Sell222222
Total181818151515

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Hongda Zhong
Jefferies
No rating
Jefferies
Buy
Maintains
$4.50
BuyMaintains$4.50+59.86%Sep 30, 2026
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$4.24
BuyMaintains$4.24+50.62%Sep 23, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
$4.20 → $3.60
HoldMaintains$4.20 → $3.60+27.89%Sep 22, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$4.50
BuyMaintains$4.50+59.86%Sep 22, 2026
Morgan Stanley
Morgan Stanley
Sell
Maintains
$4.20
SellMaintains$4.20+49.20%May 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
37.48B
from 34.26B
Increased by 9.40%
Revenue Next Year
41.27B
from 37.48B
Increased by 10.12%
EPS This Year
0.13
from 0.14
Decreased by -6.07%
EPS Next Year
0.16
from 0.13
Increased by 16.46%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
20.58B26.76B27.03B30.60B34.26B37.48B
Revenue Growth
32.60%30.06%0.99%13.22%11.95%9.40%
Gross Profit
4.11B5.70B5.90B7.43B8.21B8.98B
Gross Margin
19.96%21.30%21.81%24.29%23.97%23.97%
Operating Income
-1.10B-51.50M634.85M1.45B1.83B2.15B
Net Income
-265.56M535.65M883.48M1.43B1.94B2.04B
EPS
----0.140.13
EPS Growth
----18.78%-6.07%
Forward PE
298.27177.5138.5434.3224.3617.83
Dividend / Share
----0.060.02
Free Cash Flow
-----2.45B
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202720282029
High38.8B
Avg37.5B
Low36.7B

Revenue Growth

Revenue Growth202720282029
High
13.4%
Avg
9.4%
Low
7.1%

EPS Forecast

EPS202720282029
High0.17
Avg0.13
Low0.12

EPS Growth

EPS Growth202720282029
High
15.1%
Avg
-6.1%
Low
-15.0%